FDA Inspection 784077 — Merck And Company

Merck And Company — FEI 3003108227

The FDA completed an inspection of Merck And Company on May 2, 2012 in Springfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 2, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Springfield, NJ (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748021 CFR 312.50Ensuring compliance with plan and protocol

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.